Influence of Analgesic Technique on Post Operative Rehabilitation After Median Laparotomy
Launched by CENTRE HOSPITALIER RÉGIONAL METZ-THIONVILLE · Jul 21, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different pain relief methods affect recovery after a surgery called median laparotomy, which involves making a cut in the abdomen. The researchers want to compare two techniques for managing pain: one group of patients will receive epidural anesthesia, which involves a catheter placed near the spine to block pain, while the other group will have catheters placed in the muscles of the abdomen to provide localized pain relief.
To participate in this study, patients should be between the ages of 65 and 74, able to understand French, and scheduled for a midline laparotomy. They must also agree to participate by providing written consent. It’s important to note that some individuals may not be eligible due to certain health conditions or if they are currently involved in another clinical study. Those who join can expect to receive either of the pain management techniques and be monitored for how well they recover after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ASA (American Society of Anesthesiologists) Class I-IV adult, with programmed midline laparotomy
- • Have given an informed written consent
- • Able to read and understand french language
- • Affiliation to a social security system
- Exclusion Criteria:
- • Local anesthesic contraindication (allergy, porphyria, haemolytic anaemia, uncontrolled epilepsy, or severe cardiac conduction disorders) or TEA (coagulation disorders, progressive neurological disease, or severe spinal disorder),
- • Epidural analgesia contraindication
- • With impossibility to set up bilateral rectus sheath block
- • Participation in another clinical study
- • Pregnant women
- • Patients deprived of their liberty by a judicial or administrative decision,
- • Patients undergoing psychiatric care under articles L.3212-1 and L.3213-1 of the French Public Health Code
About Centre Hospitalier Régional Metz Thionville
The Centre Hospitalier Régional Metz-Thionville is a leading healthcare institution in the Grand Est region of France, dedicated to delivering high-quality medical care and advancing clinical research. With a multidisciplinary team of experienced healthcare professionals, the center emphasizes patient-centered services and innovative treatment approaches. Committed to enhancing medical knowledge and improving patient outcomes, the hospital actively participates in clinical trials across various therapeutic areas, fostering collaboration with academic institutions and industry partners to drive advancements in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Metz, Moselle, France
Metz, Moselle, France
Thionville, , France
Patients applied
Trial Officials
Antoine BECRET, MD
Principal Investigator
CHR Metz Thionville Hopital de Mercy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials